Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
twb-103 (1 trial)
txb-103 (1 trial)
Diabetic Foot (Phase 2)
Foot Ulcer (Phase 2)
Ulcer (Phase 2)
Trials (2 total)
Trial APIs (2 total)